Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Myelodysplastic Syndromes × Classical hematology × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 10 Other hematologic neoplasm 7 Lymphoid 1 Classical hematology 1

Conditions

Hemophilia A 4 Anemia, Sickle Cell 4 Thrombocytopenia 2 Anemia 2 Venous Thromboembolism 1 Vaso-Occlusive Crises 1 Renal Anemia 1 Purpura, Thrombocytopenic, Idiopathic 1 Purpura, Thrombocytopenic 1 Priapism 1 Ovarian Neoplasms 1 Myelodysplastic Syndromes 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Fanconi Anemia, Complementation Group D1 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02631070 2021-12-17

MEDALIST

Celgene

Phase 3 Completed

229 enrolled 36 charts 2 FDA

Classical hematologyMyeloid

Anemia, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡